188 related articles for article (PubMed ID: 19282030)
1. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
Lo A; Gu G; Liu M; Dev VG
Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
[No Abstract] [Full Text] [Related]
2. A case of ABL deletion in a patient with precursor B cell lymphoblastic leukemia.
Huh J; Moon H; Chung W
Ann Hematol; 2008 Mar; 87(3):239-41. PubMed ID: 17846770
[No Abstract] [Full Text] [Related]
3. Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
Bassan R; Rohatiner AZ; Lerede T; Di Bona E; Rambaldi A; Pogliani E; Rossi G; Fabris P; Morandi S; Casula P; Carter M; Lambertenghi-Deliliers G; Lister TA; Barbui T
Hematol J; 2000; 1(4):226-34. PubMed ID: 11920195
[TBL] [Abstract][Full Text] [Related]
4. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Layden BT; Joseph M; Tallman MS; Platanias LC
Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
[TBL] [Abstract][Full Text] [Related]
6. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
[TBL] [Abstract][Full Text] [Related]
7. ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion.
Huh J; Mun YC; Seong CM; Chung WS
Ann Hematol; 2012 Nov; 91(11):1813-5. PubMed ID: 22453304
[No Abstract] [Full Text] [Related]
8. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
[No Abstract] [Full Text] [Related]
9. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Medeiros BC
N Engl J Med; 2009 Apr; 360(17):1787; author reply 1787-8. PubMed ID: 19387020
[No Abstract] [Full Text] [Related]
10. Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia.
Andreasson P; Johansson B; Arheden K; Tedgård U; Ljung R; Heim S; Mitelmann F
Leukemia; 1996 Feb; 10(2):378-83. PubMed ID: 8637252
[No Abstract] [Full Text] [Related]
11. [An adult case of precursor B cell lymphoblastic lymphoma extending from right neck to upper cervical spinal region].
Nishihara M; Kudo H; Mizuno I; Taomoto K; Kohmura E
No Shinkei Geka; 2005 Nov; 33(11):1107-11. PubMed ID: 16277225
[TBL] [Abstract][Full Text] [Related]
12. Granular acute lymphoblastic leukemia: a case report and literature review.
Pitman SD; Huang Q
Am J Hematol; 2007 Sep; 82(9):834-7. PubMed ID: 17546641
[TBL] [Abstract][Full Text] [Related]
13. Progressive paresthesia and weakness after intrathecal chemotherapy.
Marshall R; Gupta ND; Palacios E; Neitzschman HR
J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
[No Abstract] [Full Text] [Related]
15. GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.
Koller PB; Zhang H; Kantarjian H; Jabbour E; Pierce S; Gocho Y; Roberts KG; Yang W; Mullighan CG; Yang J; Konopleva M; Jain N
Am J Hematol; 2021 Mar; 96(3):E71-E74. PubMed ID: 33275800
[No Abstract] [Full Text] [Related]
16. Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study.
Chevallier P; Huguet F; Raffoux E; Etienne A; Leguay T; Isnard F; Robillard N; Guillaume T; Delaunay J; Charbonnier A; Pigneux A; Peterlin P; Bené MC; Wegener WA; Goldenberg DM; Dombret H
Haematologica; 2015 Apr; 100(4):e128-31. PubMed ID: 25552705
[No Abstract] [Full Text] [Related]
17. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
[TBL] [Abstract][Full Text] [Related]
18. The effect of the Hyper-CVAD chemotherapy regimen on fertility and ovarian function.
Seshadri T; Hourigan MJ; Wolf M; Mollee PN; Seymour JF
Leuk Res; 2006 Apr; 30(4):483-5. PubMed ID: 16171861
[TBL] [Abstract][Full Text] [Related]
19. Nelarabine activity in acute biphenotypic leukemia.
Alvarado Y; Welch MA; Swords R; Bruzzi J; Schlette E; Giles FJ
Leuk Res; 2007 Nov; 31(11):1600-3. PubMed ID: 17512588
[No Abstract] [Full Text] [Related]
20. Management of precursor B-lymphoblastic lymphoma/leukaemia of thoracic spine in a pregnancy presenting with acute paraplegia.
Esin S; Tarim E; Abali H; Kardes O; Kocer EN; Alkan O
J Obstet Gynaecol; 2012 Jul; 32(5):485-6. PubMed ID: 22663326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
